Table 3.
Seminal plasma levels of malondialdehyde (MDA) and total antioxidant capacity (TAC) and activities of catalase (CAT) and alanine aminotransferase (ALT) enzymes in CoQ10 supplemented (CoQ10; n = 5) versus control (CON; n = 5) group at the studied time points (W0-W8) under heat stress conditions (THI: 88.3–94.4)
| W | MDA (nM/mL) | TAC (mM/L) | CAT (U/L) | ALT (U/mL) | ||||
|---|---|---|---|---|---|---|---|---|
| COQ10 | CON | COQ10 | CON | COQ10 | CON | COQ10 | CON | |
| W0 | 2.76 ± 0.01 | 2.72 ± 0.03 | 0.63 ± 0.01 | 0.60 ± 0.04 | 266.49 ± 24.45 | 267.91 ± 23.72 | 41.13 ± 1.33 | 43.06 ± 0.51 |
| W1 | 2.73 ± 0.05 | 2.78 ± 0.11 | 0.69 ± 0.01 | 0.63 ± 0.05 | 278.74 ± 28.32 | 280.58 ± 24.27 | 45.82 ± 2.41 | 44.34 ± 1.24 |
| W2 | 2.62 ± 0.01 | 2.73 ± 0.01 | 0.84 ± 0.01* | 0.64 ± 0.01 | 247.33 ± 15.97 | 256.01 ± 24.25 | 47.68 ± 2.65 | 43.62 ± 1.54 |
| W3 | 2.69 ± 0.01 | 2.77 ± 0.02 | 1.27 ± 0.01* | 0.64 ± 0.07 | 284.38 ± 26.58 | 296.42 ± 30.74 | 48.74 ± 2.01 | 43.52 ± 2.63 |
| W4 | 2.52 ± 0.02 | 2.71 ± 0.01 | 1.29 ± 0.01* | 0.88 ± 0.07 | 396.87 ± 24.31* | 299.73 ± 46.13 | 36.24 ± 0.97* | 43.36 ± 1.76 |
| W5 | 2.41 ± 0.04* | 2.77 ± 0.03 | 1.33 ± 0.01* | 0.92 ± 0.06 | 446.84 ± 15.88* | 284.40 ± 36.69 | 38.90 ± 1.74* | 47.36 ± 0.84 |
| W6 | 2.11 ± 0.05* | 2.66 ± 0.04 | 1.35 ± 0.02* | 0.96 ± 0.12 | 494.71 ± 24.65* | 309.87 ± 33.29 | 34.48 ± 4.02* | 49.78 ± 1.22 |
| W7 | 2.04 ± 0.04* | 2.68 ± 0.01 | 1.01 ± 0.02 | 0.94 ± 0.08 | 487.27 ± 15.62* | 284.01 ± 33.57 | 34.64 ± 1.22* | 44.16 ± 0.21 |
| W8 | 2.02 ± 0.04* | 2.65 ± 0.06 | 0.79 ± 0.01 | 0.84 ± 0.12 | 529.364 ± 22.31* | 299.29 ± 31.80 | 46.76 ± 2.31 | 43.55 ± 0.22 |
THI temperature humidity index, W weeks. Data obtained as mean ± SEM.*Values in each measure are different at least at P < 0.05 between the two groups. The treatment (COQ10 vs CON) and time effects showed significant (P < 0.01) differences in MDA, TAC, CAT, and ALT